Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Strategies to Improve RTS,S-4 Uptake and Integration With Other Child Health Services

11 november 2026 bijgewerkt door: Simon Kariuki, Kenya Medical Research Institute

Investigating Approaches to Increase the Uptake of Malaria Vaccine and Other Childhood Health Interventions in Western Kenya: a Feasibility Study

This study will identify and evaluate innovative approaches to leverage malaria vaccine visits as opportunities to enhance the delivery of other child health services in Rarieda sub-county, Siaya County, Kenya where RTS,S became part of their routine childhood immunization programs in 2019. Using a human-centred design approach, the implementation research will be conducted in two phases.

Phase 1 (Diagnose and Design) will consist of formative research to understand current practices, barriers, and facilitators for childhood health and malaria interventions using the WHO's behavioural and social drivers' framework for immunization. Having identified the barriers and facilitators to uptake, the investigators will prioritize drivers and develop innovations for implementation in collaboration with communities, healthcare workers and managers.

Phase 2 (Implement and Evaluate) will focus on implementing and evaluating the innovations developed in Phase 1. Using the RE-AIM (Reach, Effectiveness, Adoption, Implementation, and Maintenance) Framework, the study will assess the extent to which the interventions reach the target population, effectiveness of leveraging the malaria vaccine to increase uptake of other child health interventions, the extent of adoption by key stakeholders, and the fidelity and quality of implementation. The investigators will also explore cost and long-term sustainability.

The study will employ a mixed-methods approach, leveraging quantitative and qualitative data from health facility records, surveys, interviews, and observations.

The investigators will generate evidence on leveraging malaria vaccine visits and activities through: (i) innovative implementation strategies designed to maximize immunizations, child health interventions, and malaria prevention uptake; (ii) community engagement as an approach to optimize vaccine uptake and coverage; (iii) detailed qualitative data on the acceptability, perceptions, and barriers to uptake of vaccines and child health interventions; (iv) approaches to ensure access for zero-dose, under-vaccinated and underserved populations.

Studie Overzicht

Studietype

Ingrijpend

Inschrijving (Werkelijk)

2346

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

      • Siaya, Kenia
        • Ong'ielo Health Centre

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

18 jaar en ouder (Volwassen, Oudere volwassene)

Accepteert gezonde vrijwilligers

Ja

Geslachten die in aanmerking komen voor studie

Allemaal

Beschrijving

  1. Primary caregivers of children eligible for malaria vaccination:

    • Inclusion criteria: Primary caregivers (age 18 years or older) of children who are eligible for or have received at least one dose of malaria vaccine
    • Exclusion criteria: Caregivers who are not the primary decision-makers for the child's healthcare or who have resided in the study area for less than 3 months
  2. Healthcare workers involved in immunization services:

    • Inclusion criteria: Clinical officers, nurses, or other healthcare staff directly involved in providing immunization services at the selected health facilities for at least 3 months
    • Exclusion criteria: Healthcare workers not involved in immunization service delivery or who have worked at the facility for less than 3 months
  3. Community health promoters (CHPs):

    • Inclusion criteria: CHPs working in the catchment areas of selected health facilities for at least 6 months
    • Exclusion criteria: CHPs who have not been active in the past 3 months
  4. Community members and leaders:

    • Inclusion criteria: community members and leaders willing to share their views on malaria vaccine barriers and facilitators, and approaches to improve uptake.
    • Exclusion criteria: Community members not willing to participate in the study
  5. Health facility managers and sub-county/county/national health officials:

    • Inclusion criteria: Health facility in-charges, sub-county or county EPI coordinators, and other relevant health officials overseeing immunization services across MoH hierarchy
    • Exclusion criteria: Officials who have been in their current position for less than 3 months

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Preventie
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Geen (open label)

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: ITN - Provision of ITNs at RTS,S-4 visit

Leverage malaria vaccine to improve ITN access and use by providing ITNs at the 4th malaria dose visit, as well as vitamin A, deworming, MR2 and other missing vaccines

- At RTS,S-4 visit, health workers (HW) screen children for missing vaccinations and health services - HW provide catch-up vaccinations and services

Experimenteel: CHP - CHP identify and refer under-vaccinated children to health facility

Using malaria vaccine as an entry point, CHPs systematically identified under-vaccinated children during routine household visits and referred them to health facilities (HF), integrating immunization tracking into routine community activities.

  • CHP screen households for under-vaccinated children
  • CHP Provide referral for immunization
  • HW vaccinate referred children
  • HW provide catch-up vaccinations and services
  • CHP follow up on referral completion
Experimenteel: SMS - Enhanced defaulter tracing with use of mobile technology

Facility-community linkages were strengthened through CHP engagement and mobile phone-based reminders, including SMS notifications and defaulter tracing

  • HF diaries to record expected children on each date
  • HW record phone contacts in diaries to remind caregivers about visits (SMS or calls)
  • If caregivers cannot be reached, HW share contacts by SMS/WhatsApp with CHPs to trace defaulters at the house and provide referrals
  • HW screen & provide catch-up vaccinations & services
Experimenteel: SS - Strengthening immunization systems, health services, and interdepartmental collaboration

Multi-component intervention: 1) strengthening immunizations and health services through interdepartmental collaboration; 2) improving vaccine visit awareness, preparedness, and defaulter tracing; and 3) targeted monthly community outreaches, with CHPs mobilizing caregivers of children due or overdue for vaccination.

  • Screening children for vaccination status at triage
  • HW use colored ink to better visualize return dates in home-based records
  • HW Screen & provide catch-up vaccinations & services
  • CHPs trace defaulters, provide & follow up on referrals
  • HF diaries to record expected children on each date
  • HF conduct targeted community outreaches
  • CHP mobilize defaulters for scheduled outreaches

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Reach
Tijdsspanne: Three months

Vaccine coverage (%) in target populations and characteristics of vaccinated populations reached through study interventions

Three months
Effectiveness
Tijdsspanne: Three months

Percentage increase in primary (dose 1-3) and booster (4th) doses post-interventions in age-eligible children

Three months
Adoption
Tijdsspanne: Three months

Proportion of RTS,S vaccines provided concurrently with other vaccines/services.

Three months
Implementation
Tijdsspanne: Three months

Perceived feasibility of interventions by health workers, caregivers, and community. A semi-structured interview guide will be used to assess implementation experiences.

Three months
Maintenance
Tijdsspanne: Three months

Drivers of maintenance of interventions. A semi-structured interview guide will be used to elicit what it would take to continue implementing interventions beyond the study period.

Three months

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Onderzoekers

  • Hoofdonderzoeker: Simon Kariuki, PhD, Kenya Medical Research Institute
  • Hoofdonderzoeker: Nelli Westercamp, PhD, Centres for Disease Control and Prevention

Publicaties en nuttige links

De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.

Algemene publicaties

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

1 juli 2025

Primaire voltooiing (Werkelijk)

4 december 2025

Studie voltooiing (Werkelijk)

4 december 2025

Studieregistratiedata

Eerst ingediend

22 oktober 2026

Eerst ingediend dat voldeed aan de QC-criteria

11 november 2026

Eerst geplaatst (Werkelijk)

17 november 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

17 november 2026

Laatste update ingediend die voldeed aan QC-criteria

11 november 2026

Laatst geverifieerd

1 november 2026

Meer informatie

Termen gerelateerd aan deze studie

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

NEE

Beschrijving IPD-plan

Only aggregated data is required for reports and manuscripts.

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren